NewGenIvf (NIVF) Debt to Equity (2024 - 2025)
NewGenIvf (NIVF) reported Debt to Equity of $0.02 for Q4 2025, up 135.82% year-over-year from $0.01 in Q4 2024, and down 41.33% quarter-over-quarter from $0.03 in Q2 2025.
NewGenIvf (NIVF) Debt to Equity (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has 2 years of Debt to Equity data on file, last reported at $0.02 in Q4 2025.
- Debt to Equity for Q4 2025 came in at $0.02, up 135.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.02 (up 135.82% YoY), and the FY2025 annual result was $0.02, up 135.82% from the prior year.
- Debt to Equity declined to $0.02 in Q4 2025 per NIVF's latest filing, from $0.03 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.03 in Q2 2025 and troughed at -$0.05 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | -16.13 |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 2.74 |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | -22.31 |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 0.78 |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 0.06 |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 0.63 |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 0.51 |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 0.11 |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 0.05 |
| 10 | NewGenIvf | - | - | 524,025.00 | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.02 |
| Jun 30, 2025 | 0.03 |
| Dec 31, 2024 | -0.05 |